Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease [NA]

View source ↗

Summary

This document reports a clinical trial evaluating the safety and preliminary efficacy of EXG110 in Fabry disease, with the study currently recruiting and sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXG110

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Fabry Disease | NA | Status: RECRUITING